6.97 USD
↗ 0.04 (0.58%)PRE MARKET (AS OF 04:06 AM EDT)
Alumis Inc. Common Stock
ALMSNASDAQ • USD
Market: OPEN
Shares of Alumis Inc. Common Stock (ALMS) are trading at $6.97. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Strong Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ALMS at a fair price relative to peers.
Technical & fundamental data as of Oct 6, 2026.
Open?$6.97
High?$6.97
Low?$6.97
Prev. Close?$6.93
Volume?8
Avg. Volume?4.0M
VWAP?$6.97
Rel. Volume?0.00x
Bid / Ask
Bid?$5.75 × 100
Ask?$8.10 × 100
Spread?$2.35
Midpoint?$6.93
Valuation & Ratios
Market Cap?897.0M
Shares Out?129.4M
Float?74.5M
Float %?60.4%
P/E Ratio?N/A
P/B Ratio?1.98
EPS?-$3.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Themes
Employees
239
Market Cap
897.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-06-28
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?5
Momentum?10
Short Sent.?68
Piotroski F-Score?1/9Weak
Altman Z-Score?0.37Distress
Confidence?58%Low
Short InterestElevated
Short % of Float?8.46%Elevated
Short Interest?6.3M
Days to Cover?1.0
Free Float74.5M
Avg Daily Volume7.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?6.74Strong
Quick Ratio?6.74Strong
Cash Ratio?0.84Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.98CHEAP▾
Peers100
S&P74
P/S?121.25HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.0CHEAP▾
S&P97
EV/Sales?112.64HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-97.1%WEAK▾
S&P3
ROA?-78.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-351799000
Enterprise Value?$833.3M
Fundamentals ratios updated end of day